Depression and Anxiety Trial, Recruiting NCT07480668 Sponsor: Federal University of Minas Gerais Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07480668
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 years or older
  • People who have been diagnosed with infertility and have been recommended for IVF (In Vitro Fertilization, a fertility treatment)
  • People who are currently on the waiting list at HC-UFMG (a specific hospital in Brazil)
  • People who are willing to avoid other mind-body practices (such as meditation programs) or herbal therapies for the duration of the study
  • People whose screening results on a questionnaire called the DASS-21 show at least mild levels of anxiety, stress, and/or depression
  • People who have no aversion to inhaling lavender essential oil or a synthetic lavender scent

Who may not be able to join:

  • People with severe neurological, psychiatric, or other serious medical conditions (for example, schizophrenia or severe depression) that would prevent them from taking part
  • People who have used certain medications — such as sleeping tablets, anti-anxiety medications, antidepressants, or antipsychotics — in the 30 days before the study or who would need to use them during the study
  • People with a known allergy to lavender products
  • People who become pregnant during the study period
  • People who have used essential oils in the 90 days before joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bárbara P Aquino, MSc, Federal University of Minas Gerais

Phone: +55 31 3409-9764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Federal University of Minas Gerais
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change from Baseline in Depression, Anxiety, and Stress Scale (DASS-21) Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov